Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 401
- 试验地点
- 3
- 主要终点
- Proportion of participants who would recommend outside-of-center administration to a friend
研究概览
简要总结
This study will test ways to give women more options and flexibility when they are ending their unwanted pregnancies. The investigators will look at uptake and acceptability of using mifepristone outside of the clinic for pregnancy termination.
详细描述
This study will investigate the uptake of mifepristone administration outside of the health center for pregnancy termination and its acceptability to women and to their providers. In addition, we plan to evaluate rates of follow-up, adherence, efficacy, complications, days of missed work and/or school, and lost income. This will be a prospective, comparative, non-randomized, open-label study. All women who are seeking medical abortion will be offered participation in the study. Women who enroll in the study will be given a choice between taking the mifepristone outside the center or in the center setting.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Women 18 years and older
- •seeking medical abortion services
- •in general good health
- •assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken
- •eligible for medical abortion according to clinician and center standards.
排除标准
- •will be followed up by beta HCG and not ultrasound
研究组 & 干预措施
Out-of-Center Use of Mifepristone
Participants who choose to take the mifepristone outside of the center
干预措施: Mifepristone (Drug)
结局指标
主要结局
Proportion of participants who would recommend outside-of-center administration to a friend
时间窗: 1-2 weeks
Proportion of participants who would choose outside of center administration of mifepristone again
时间窗: 1-2 weeks
次要结局
- Proportion of women who select outside-of-clinic use of mifepristone(1-2 weeks)
- Adherence(1-2 weeks)
- Success Rates/Method Failure(1-2 weeks)
- Provider-related outcomes(1-2 weeks)